EXOLYTICS
ExoLytics is an early-stage biotechnology company focused on developing novel, innovative, and disruptive technologies to combat drug-resistant infectious diseases.
EXOLYTICS
Social Links:
Industry:
Biotechnology
Founded:
2020-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.exolytics.com
Total Employee:
1+
Status:
Active
Contact:
+1 703 688 3107
Total Funding:
10 K USD
Similar Organizations
Asta
Asta Ltd is an early stage food biotechnology company.
Bacilligen
Bacilligen is an early-stage Biotechnology Company
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
T-Cypher Bio
T-Cypher Bio is an early-stage biotechnology company.
Current Employees Featured
Founder
Official Site Inspections
http://www.exolytics.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 13.248.243.5
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109

More informations about "ExoLytics"
ExoLytics Inc.
ExoLytics is an early-stage biotechnology startup focused on developing novel, innovative, and disruptive technologies to combat drug-resistant infectious diseases. The company harnesses โฆSee details»
ExoLytics - Crunchbase Company Profile & Funding
Organization. ExoLytics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... ExoLytics is an early-stage biotechnology โฆSee details»
ExoLytics - The Org
ExoLytics is an early-stage biotechnology company focused on developing novel, innovative, and disruptive technologies to combat drug-resistant infectious diseases. Industries. โฆSee details»
ExoLytics - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Sep 14, 2020: Seed Round - โฆSee details»
ExoLytics - Products, Competitors, Financials, Employees, โฆ
ExoLytics primarily serves the healthcare sector, aiming to address the growing challenge of antimicrobial resistance. It was founded in 2020 and is based in Rockville, Maryland. โฆSee details»
ExoLytics - VentureRadar
ExoLytics is an early-stage biotechnology startup focused on developing novel, innovative, and disruptive technologies to combat drug-resistant infectious diseases. The company harnesses โฆSee details»
ExoLytics - Tech Stack, Apps, Patents & Trademarks - Crunchbase
ExoLytics is an early-stage biotechnology company. Experience the new Crunchbase, powered by AISee details»
ExoLytics - Biotech Careers
ExoLytics is an early-stage biotechnology startup focused on developing technologies to combat drug-resistant infectious diseases. The company harnesses endolysins, enzymes present in โฆSee details»
Exolytics, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Exolytics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
ExoLytics - Overview, News & Similar companies | ZoomInfo.com
Who is ExoLytics. The company harnesses endolysins, enzymes present in nature, to engineer safe, rapid, and effective antimicrobial therapies. The rise in antimicrob ial drug resistance, โฆSee details»
ExoLytics, Inc. - fund raising filing - Form Ds
ExoLytics, Inc. - Most recent fund raising on September 14, 2020 raised $10,000 in Equity. FormDs.com . Newest; Filter; Local; ExoLytics, Inc. Industry: Biotechnology (See others in โฆSee details»
James Saropoulos - Founder & CEO at ExoLytics - The Org
Founder & CEO at ExoLytics. Contact. No bio yet. Org chart. JS. James Saropoulos. Founder & CEO. Sign up to view 0 direct reports. Get started. Teams. This person is not in any teams. โฆSee details»
ExoLytics, Inc. - Golden
ExoLytics, Inc. is a Rockville, Maryland-based company founded in 2020. Overview Structured Data Issues Contributors Activity. ContentsSee details»
ExoLytics - Crunchbase
ExoLytics is an early-stage biotechnology company. Start Free Trial . Chrome ExtensionSee details»
ExoLytics - bacteriophage.news
Mar 30, 2022 ExoLytics is an early-stage biotechnology startup focused on developing novel, innovative, and disruptive technologies to combat drug-resistant infectious diseases. The โฆSee details»
ExoLytic | ISO
Elevate your organization with ExoLytic's unique Quality Management and Performance Enhancement consulting. Whether you seek to enhance your existing strengths or identify โฆSee details»
ExoLytics | CipherBio
Explore ExoLytics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
ExoLytics - 2025 Founders and Board of Directors - Tracxn
Apr 12, 2025 Neo Wealth-Mumbai based, 2021 founded, Seed company; Neoble-Mumbai based, 2023 founded, Seed company; INSITEK-Jakarta based, 2014 founded,. Unfunded โฆSee details»
About Us | ExoLytic
We believe in establishing efficient and robust management systems that evolve and self-improve, ensuring lasting success for your organization. How We Help Whether you need a refresh on โฆSee details»
How the American Right Learned to Love Psychedelics
1 day ago Now his organizationโs corporate spinoff, Lykos Therapeutics, may soon be acquired by Antonio Gracias, a billionaire private equity investor and close friend of the richest man in โฆSee details»